Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & EnergyDetailed TOC of China Noninvasive Cancer Diagnostics Market Report & Forecast 2021-2027
1 Introduction to Research & Analysis Reports1.1 Noninvasive Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Noninvasive Cancer Diagnostics Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Noninvasive Cancer Diagnostics Overall Market Size
2.1 China Noninvasive Cancer Diagnostics Market Size: 2021 VS 2027
2.2 China Noninvasive Cancer Diagnostics Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Noninvasive Cancer Diagnostics Players in China Market
3.2 Top China Noninvasive Cancer Diagnostics Companies Ranked by Revenue
3.3 China Noninvasive Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Noninvasive Cancer Diagnostics Companies in China Market, by Revenue in 2020
3.5 Companies Noninvasive Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Noninvasive Cancer Diagnostics Players in China Market
3.6.1 List of Tier 1 Noninvasive Cancer Diagnostics Companies in China
3.6.2 List of Tier 2 and Tier 3 Noninvasive Cancer Diagnostics Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Noninvasive Cancer Diagnostics Market Size Markets, 2021 & 2027
4.1.2 Clinical Chemistry
4.1.3 Immunochemistry/Immunoassay
4.1.4 Molecular Diagnostics
4.1.5 Others
4.2 By Type - China Noninvasive Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - China Noninvasive Cancer Diagnostics Revenue, 2016-2021
4.2.2 By Type - China Noninvasive Cancer Diagnostics Revenue, 2022-2027
4.2.3 By Type - China Noninvasive Cancer Diagnostics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Noninvasive Cancer Diagnostics Market Size, 2021 & 2027
5.1.2 Solid Tumors
5.1.3 Blood Cancer
5.1.4 Lung Cancer
5.1.5 Breast Cancer
5.1.6 Others
5.2 By Application - China Noninvasive Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - China Noninvasive Cancer Diagnostics Revenue, 2016-2021
5.2.2 By Application - China Noninvasive Cancer Diagnostics Revenue, 2022-2027
5.2.3 By Application - China Noninvasive Cancer Diagnostics Revenue Market Share, 2016-2027
6 Noninvasive Cancer Diagnostics Companies Profiles
6.1 Precision Therapeutics, Inc. (U.S.)
6.1.1 Precision Therapeutics, Inc. (U.S.) Company Details
6.1.2 Precision Therapeutics, Inc. (U.S.) Business Overview
6.1.3 Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
6.1.4 Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021)
6.1.5 Precision Therapeutics, Inc. (U.S.) Recent Developments
6.2 A&G Pharmaceutical, Inc. (U.S.)
6.2.1 A&G Pharmaceutical, Inc. (U.S.) Company Details
6.2.2 A&G Pharmaceutical, Inc. (U.S.) Business Overview
6.2.3 A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
6.2.4 A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021)
6.2.5 A&G Pharmaceutical, Inc. (U.S.) Recent Developments
6.3 Affymetrix Inc. (U.S.)
6.3.1 Affymetrix Inc. (U.S.) Company Details
6.3.2 Affymetrix Inc. (U.S.) Business Overview
6.3.3 Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
6.3.4 Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021)
6.3.5 Affymetrix Inc. (U.S.) Recent Developments
6.4 AVIVA Biosciences Corporation (U.S.)
6.4.1 AVIVA Biosciences Corporation (U.S.) Company Details
6.4.2 AVIVA Biosciences Corporation (U.S.) Business Overview
6.4.3 AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Introduction
6.4.4 AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021)
6.4.5 AVIVA Biosciences Corporation (U.S.) Recent Developments
6.5 BIOVIEW Inc. (U.S.)
6.5.1 BIOVIEW Inc. (U.S.) Company Details
6.5.2 BIOVIEW Inc. (U.S.) Business Overview
6.5.3 BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
6.5.4 BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021)
6.5.5 BIOVIEW Inc. (U.S.) Recent Developments
6.6 Laboratory Corporation of America Holdings (LabCorp) (U.S.)
6.6.1 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Company Details
6.6.2 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Business Overview
6.6.3 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Introduction
6.6.4 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021)
6.6.5 Laboratory Corporation of America Holdings (LabCorp) (U.S.) Recent Developments
6.7 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)
6.7.1 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Company Details
6.7.2 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Business Overview
6.7.3 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
6.7.4 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021)
6.7.5 Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Recent Developments
6.8 Digene Corporation (U.S.)
6.8.1 Digene Corporation (U.S.) Company Details
6.8.2 Digene Corporation (U.S.) Business Overview
6.8.3 Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Introduction
6.8.4 Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021)
6.8.5 Digene Corporation (U.S.) Recent Developments
6.9 Gen-Probe Incorporated (U.S.)
6.9.1 Gen-Probe Incorporated (U.S.) Company Details
6.9.2 Gen-Probe Incorporated (U.S.) Business Overview
6.9.3 Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Introduction
6.9.4 Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021)
6.9.5 Gen-Probe Incorporated (U.S.) Recent Developments
6.10 IVDiagnostics, Inc. (U.S.)
6.10.1 IVDiagnostics, Inc. (U.S.) Company Details
6.10.2 IVDiagnostics, Inc. (U.S.) Business Overview
6.10.3 IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Introduction
6.10.4 IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021)
6.10.5 IVDiagnostics, Inc. (U.S.) Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Figures, Tables and Charts Available in China Noninvasive Cancer Diagnostics Market Report & Forecast 2021-2027
List of TablesTable 1. Noninvasive Cancer Diagnostics Market Opportunities & Trends in China Market
Table 2. Noninvasive Cancer Diagnostics Market Drivers in China Market
Table 3. Noninvasive Cancer Diagnostics Market Restraints in China Market
Table 4. Key Players of Noninvasive Cancer Diagnostics in China Market
Table 5. Top Noninvasive Cancer Diagnostics Players in China Market, Ranking by Revenue (2019)
Table 6. China Noninvasive Cancer Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Noninvasive Cancer Diagnostics Revenue Share by Companies, 2016-2021
Table 8. Companies Noninvasive Cancer Diagnostics Product Type
Table 9. List of Tier 1 Noninvasive Cancer Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Noninvasive Cancer Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – China Noninvasive Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Noninvasive Cancer Diagnostics Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Noninvasive Cancer Diagnostics Revenue (US$, Mn), 2022-2027
Table 14. By Application – China Noninvasive Cancer Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Noninvasive Cancer Diagnostics Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Noninvasive Cancer Diagnostics Revenue (US$, Mn), 2022-2027
Table 17. Precision Therapeutics, Inc. (U.S.) Company Details
Table 18. Precision Therapeutics, Inc. (U.S.) Business Overview
Table 19. Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 20. Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Precision Therapeutics, Inc. (U.S.) Recent Developments
Table 22. A&G Pharmaceutical, Inc. (U.S.) Company Details
Table 23. A&G Pharmaceutical, Inc. (U.S.) Business Overview
Table 24. A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 25. A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 26. A&G Pharmaceutical, Inc. (U.S.) Recent Developments
Table 27. Affymetrix Inc. (U.S.) Company Details
Table 28. Affymetrix Inc. (U.S.) Business Overview
Table 29. Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 30. Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Affymetrix Inc. (U.S.) Recent Developments
Table 32. AVIVA Biosciences Corporation (U.S.) Company Details
Table 33. AVIVA Biosciences Corporation (U.S.) Business Overview
Table 34. AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Product
Table 35. AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 36. AVIVA Biosciences Corporation (U.S.) Recent Developments
Table 37. BIOVIEW Inc. (U.S.) Company Details
Table 38. BIOVIEW Inc. (U.S.) Business Overview
Table 39. BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 40. BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 41. BIOVIEW Inc. (U.S.) Recent Developments
Table 42. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Company Details
Table 43. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Business Overview
Table 44. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Product
Table 45. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Recent Developments
Table 47. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Company Details
Table 48. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Business Overview
Table 49. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 50. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Recent Developments
Table 52. Digene Corporation (U.S.) Company Details
Table 53. Digene Corporation (U.S.) Business Overview
Table 54. Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Product
Table 55. Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Digene Corporation (U.S.) Recent Developments
Table 57. Gen-Probe Incorporated (U.S.) Company Details
Table 58. Gen-Probe Incorporated (U.S.) Business Overview
Table 59. Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Product
Table 60. Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Gen-Probe Incorporated (U.S.) Recent Developments
Table 62. IVDiagnostics, Inc. (U.S.) Company Details
Table 63. IVDiagnostics, Inc. (U.S.) Business Overview
Table 64. IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Product
Table 65. IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue in China Market (2016-2021) & (US$ Million)
Table 66. IVDiagnostics, Inc. (U.S.) Recent Developments
List of Figures
Figure 1. Noninvasive Cancer Diagnostics Segment by Type
Figure 2. Noninvasive Cancer Diagnostics Segment by Application
Figure 3. China Noninvasive Cancer Diagnostics Market Overview: 2020
Figure 4. China Noninvasive Cancer Diagnostics Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Noninvasive Cancer Diagnostics Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Noninvasive Cancer Diagnostics Revenue in 2020
Figure 7. By Type - China Noninvasive Cancer Diagnostics Revenue Market Share, 2016-2027
Figure 8. By Application - China Noninvasive Cancer Diagnostics Revenue Market Share, 2016-2027
Figure 9. Precision Therapeutics, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. A&G Pharmaceutical, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Affymetrix Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. AVIVA Biosciences Corporation (U.S.) Noninvasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. BIOVIEW Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Laboratory Corporation of America Holdings (LabCorp) (U.S.) Noninvasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Digene Corporation (U.S.) Noninvasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Gen-Probe Incorporated (U.S.) Noninvasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. IVDiagnostics, Inc. (U.S.) Noninvasive Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Keyplayers in China Noninvasive Cancer Diagnostics Market Report & Forecast 2021-2027
Precision Therapeutics, Inc. (U.S.)A&G Pharmaceutical, Inc. (U.S.)
Affymetrix Inc. (U.S.)
AVIVA Biosciences Corporation (U.S.)
BIOVIEW Inc. (U.S.)
Laboratory Corporation of America Holdings (LabCorp) (U.S.)
Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)
Digene Corporation (U.S.)
Gen-Probe Incorporated (U.S.)
IVDiagnostics, Inc. (U.S.)
REQUEST COMPANIES MENTIONED IN THIS REPORT
